Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01331824
What this trial is testing

Trial of Amrubicin as Second-Line Therapy in Patients With Advanced/Metastatic Refractory Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Matthew Galsky 22
Testing effectiveness (Phase 2)Study completedNCT03785925
What this trial is testing

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmNeoplasm Metastasis
Nektar Therapeutics 192
Testing effectiveness (Phase 2)Ended earlyNCT05012397
What this trial is testing

Milademetan in Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorsHead and Neck CarcinomaCholangiocarcinoma+15 more
Rain Oncology Inc 40
Testing effectiveness (Phase 2)UnknownNCT00006118
What this trial is testing

Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Early research (Phase 1)Not Yet RecruitingNCT07217496
What this trial is testing

N-803 in Combination With Pembrolizumab and Enfortumab Vedotin for Treatment of Urothelial Cancer

Who this might be right for
Metastatic Urothelial CarcinomaUrothelial CarcinomaLocally Advanced Urothelial Carcinoma+2 more
ImmunityBio, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06770582
What this trial is testing

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Who this might be right for
Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8
National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT02581982
What this trial is testing

Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer

Who this might be right for
Transitional Cell Carcinoma
Wake Forest University Health Sciences 27
Testing effectiveness (Phase 2)Ended earlyNCT03912818
What this trial is testing

Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Who this might be right for
Bladder AdenocarcinomaBladder Mixed AdenocarcinomaBladder Squamous Cell Carcinoma+9 more
Stanford University 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05200988
What this trial is testing

Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC

Who this might be right for
Urothelial CarcinomaBladder Cancer
The Netherlands Cancer Institute 50
Not applicableLooking for participantsNCT06040762
What this trial is testing

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaUpper Tract Urothelial Carcinoma+1 more
University of Washington 128
Testing effectiveness (Phase 2)Looking for participantsNCT05706129
What this trial is testing

Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Clear Cell Renal Cell Cancer (ccRCC)Pancreatic Ductal Adenocarcinoma (PDAC)Colorectal Cancer (CRC)+6 more
Lumara Bio Oncologics GmbH 270
Not applicableNot Yet RecruitingNCT04167332
What this trial is testing

Prospective Collection of Samples for Urothelial Cancer of Bladder

Who this might be right for
Bladder Cancer
Universitaire Ziekenhuizen KU Leuven 630
Not applicableActive Not RecruitingNCT02968732
What this trial is testing

Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial Carcinoma
Fox Chase Cancer Center 65
Early research (Phase 1)Looking for participantsNCT05521698
What this trial is testing

Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial Carcinoma
University of Wisconsin, Madison 80
Early research (Phase 1)Study completedNCT03854721
What this trial is testing

Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

Who this might be right for
Urothelial Carcinoma of the Urinary Bladder
Vaxiion Therapeutics 6
Testing effectiveness (Phase 2)Ended earlyNCT04985604
What this trial is testing

Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors

Who this might be right for
MelanomaSolid TumorCRAF Gene Amplification+20 more
Day One Biopharmaceuticals, Inc. 23
Large-scale testing (Phase 3)Study completedNCT00033436
What this trial is testing

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 330
Testing effectiveness (Phase 2)WithdrawnNCT01639521
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Who this might be right for
Anterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral Cancer+7 more
University of Southern California
Not applicableNot Yet RecruitingNCT06727214
What this trial is testing

Survival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Urothelial Carcinoma
Sara Mahmoud Ahmed Mahmoud 87
Testing effectiveness (Phase 2)UnknownNCT05328336
What this trial is testing

Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter Study

Who this might be right for
Muscle Invasive Bladder Cancer Urothelial Carcinoma
Tianjin Medical University Second Hospital 74
Next Page